Apimeds Pharmaceuticals US, Inc. (APUS) — Defensive Interval Ratio
Apimeds Pharmaceuticals US, Inc. (APUS) has a Defensive Interval Ratio of 38 days as of March 2026. Defensive assets of $1.50 Million (cash $-, short-term investments $1.50 Million, receivables $-) cover 38 days of daily cash needs of $39.96K/day. Explore Apimeds Pharmaceuticals US, Inc. (APUS) long-term investment share to see how much of total assets are deployed in long-term investments.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apimeds Pharmaceuticals US, Inc. Defensive Interval Ratio (2025–2025)
This chart shows how Apimeds Pharmaceuticals US, Inc.'s Defensive Interval Ratio has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the ratio stands at 38 days, meaning defensive assets of $1.50 Million can fund 38 days of operations without new revenue. Read Apimeds Pharmaceuticals US, Inc. debt and liabilities for a breakdown of total debt and financial obligations.
Annual Defensive Interval Ratio for Apimeds Pharmaceuticals US, Inc. (2025–2025)
The table below presents the year-by-year Defensive Interval Ratio for Apimeds Pharmaceuticals US, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Apimeds Pharmaceuticals US, Inc. asset portfolio.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 68 days | $2.00 Million | $29.33K/day | $- | $2.00 Million | — |